Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Van Tellingen

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Journal of Chromatography. B, Biomedical Sciences and Applications|July 20, 1999
Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4-hydrazino-2-stilbazoleR W Sparidans, J J Kettenes-van den Bosch, O van Tellingen, et al.
Journal of Chromatography. B, Biomedical Applications|May 19, 1995
Analytical procedure for the determination of the new antitumour drug N-benzoylstaurosporine and three potential metabolites in human plasma by reversed-phase high-performance liquid chromatographyR van Gijn, O van Tellingen, J J de Clippeleir, et al.
British Journal of Cancer|November 27, 2001
The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patientsM M Malingré, J H Schellens, O Van Tellingen, et al.
Neuro-Oncology|June 16, 2025
Cranial radiotherapy profoundly affects glia without inducing widespread cellular senescenceL E Kuil, R H van Scheppingen, Y M Leter, et al.
Anti-Cancer Drugs|December 29, 2000
Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol) and carboplatin in non-small cell lung cancer patientsJ Meerum Terwogt, O van Tellingen, V R Nannan Panday, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I study of vintriptol, a tryptophan ester of vinblastineH M Oosterkamp, L T Vlasveld, J Wanders, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell linesP J van de Vaart, N van der Vange, F A Zoetmulder, et al.
Cell|May 20, 1994
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsA H Schinkel, J J Smit, O van Tellingen, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteinsA H Schinkel, U Mayer, E Wagenaar, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2006
Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout miceM L H Vlaming, K Mohrmann, E Wagenaar, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Journal of Chromatography. B, Biomedical Sciences and Applications|July 20, 1999
Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4-hydrazino-2-stilbazoleR W Sparidans, J J Kettenes-van den Bosch, O van Tellingen, et al.
Journal of Chromatography. B, Biomedical Applications|May 19, 1995
Analytical procedure for the determination of the new antitumour drug N-benzoylstaurosporine and three potential metabolites in human plasma by reversed-phase high-performance liquid chromatographyR van Gijn, O van Tellingen, J J de Clippeleir, et al.
British Journal of Cancer|November 27, 2001
The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patientsM M Malingré, J H Schellens, O Van Tellingen, et al.
Neuro-Oncology|June 16, 2025
Cranial radiotherapy profoundly affects glia without inducing widespread cellular senescenceL E Kuil, R H van Scheppingen, Y M Leter, et al.
Anti-Cancer Drugs|December 29, 2000
Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol) and carboplatin in non-small cell lung cancer patientsJ Meerum Terwogt, O van Tellingen, V R Nannan Panday, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I study of vintriptol, a tryptophan ester of vinblastineH M Oosterkamp, L T Vlasveld, J Wanders, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell linesP J van de Vaart, N van der Vange, F A Zoetmulder, et al.
Cell|May 20, 1994
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsA H Schinkel, J J Smit, O van Tellingen, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteinsA H Schinkel, U Mayer, E Wagenaar, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2006
Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout miceM L H Vlaming, K Mohrmann, E Wagenaar, et al.
Pageof 10